Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 47

    Lannett gets USFDA nod for Butalbital, Acetaminophen and Caffeine Capsules

    Lannett gets USFDA nod for Butalbital, Acetaminophen and Caffeine Capsules

    Medical Dialogues Bureau27 Dec 2019 9:20 AM IST
    The two dosage strengths of BAC Capsules, have a combined estimated IQVIA market value of approximately $68.6 million for the 12 months ending October...
    Dishman Carbogen shares rise by 9 pc after I-T department conducts search at offices

    Dishman Carbogen shares rise by 9 pc after I-T department conducts search at offices

    Medical Dialogues Bureau26 Dec 2019 4:29 PM IST
    Ahmedabad: The share price of Dishman Carbogen Amcis rose by over 9 per cent on Thursday after officials of the Income Tax Department conducted search...
    Allergan signs $750 million settlement with purchasers of Alzheimer

    Allergan signs $750 million settlement with purchasers of Alzheimer's drug Namenda

    Medical Dialogues Bureau26 Dec 2019 2:24 PM IST
    NEW YORK: Purchasers of Allergan Plc's Namenda asked a federal judge on Tuesday to approve a $750 million settlement of claims that the drugmaker...
    Piramal Enterprises to raise Rs 2,750 crore by issuing bonds on private placement basis.

    Piramal Enterprises to raise Rs 2,750 crore by issuing bonds on private placement basis.

    Medical Dialogues Bureau26 Dec 2019 2:23 PM IST
    Mumbai: Piramal Enterprises said on Wednesday that it will raise up to Rs 2,750 crore by issuing bonds on private placement basis."A meeting of the...
    Eurolife Healthcare acquires intravenous infusion business of Teva, Hungary

    Eurolife Healthcare acquires intravenous infusion business of Teva, Hungary

    Medical Dialogues Bureau26 Dec 2019 9:23 AM IST
    New Delhi: Drug firm Eurolife Healthcare on Tuesday said it has completed the acquisition of intravenous (IV) infusion business of Teva Pharmaceutical...
    Punjab: 50-year-old pharmacist harassed, blackmailed, extorted of Rs 6 lakh; constable held

    Punjab: 50-year-old pharmacist harassed, blackmailed, extorted of Rs 6 lakh; constable held

    Medical Dialogues Bureau25 Dec 2019 12:00 PM IST
    Punjab: A city-based pharmacist became a victim of extortion from none other than a police constable, who was recently arrested for taking Rs 6 lakh...
    Alembic Pharma glaucoma drug Travoprost Ophthalmic Solution gets USFDA approval

    Alembic Pharma glaucoma drug Travoprost Ophthalmic Solution gets USFDA approval

    Medical Dialogues Bureau25 Dec 2019 9:55 AM IST
    The USFDA approved Travoprost Ophthalmic Solution is a generic equivalent to Alcon Pharmaceuticals' Travatan Ophthalmic Solution, Alembic...
    Granules India gets USFDA nod for allergy treatment drug Loratadine

    Granules India gets USFDA nod for allergy treatment drug Loratadine

    Medical Dialogues Bureau25 Dec 2019 9:50 AM IST
    "The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India Ltd, for Loratadine...
    Roche to pay USD 1.15 billion to Sarepta for gene therapy licensing deal

    Roche to pay USD 1.15 billion to Sarepta for gene therapy licensing deal

    Medical Dialogues Bureau25 Dec 2019 9:32 AM IST
    Roche will make an upfront payment of $750 million in cash and take a $400 million stake in Sarepta, priced at $158.59 per share, a premium of about...
    Merck KEYTRUDA gets Japanese nod for head, neck cancer

    Merck KEYTRUDA gets Japanese nod for head, neck cancer

    Medical Dialogues Bureau25 Dec 2019 9:30 AM IST
    New Delhi: Merck, known as MSD outside the United States and Canada, recently announced that KEYTRUDA, Merck’s anti-PD-1 therapy, received new...
    Sunovion Pharma resubmits application to USFDA for sublingual Apomorphine to treat Parkinsons disease

    Sunovion Pharma resubmits application to USFDA for sublingual Apomorphine to treat Parkinsons disease

    Farhat Nasim25 Dec 2019 9:15 AM IST
    New Delhi: Sunovion Pharmaceuticals Inc. (Sunovion) recently announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug...
    Sick, loss-making Hindustan Antibiotics up for sale: Minister

    Sick, loss-making Hindustan Antibiotics up for sale: Minister

    Medical Dialogues Bureau24 Dec 2019 6:00 PM IST
    New Delhi: Loss making Hindustan Antibiotics Limited (HAL) is going to be sold off based on the recommendations of a Committee of Ministers.The...
    PrevNext

    Popular Stories

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...

    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok